An Indiana Senate bill seeking funding for research into medical applications of psilocybin was passed unanimously by the Senate Committee on Health and Provider Services on Wednesday.
Jan 19, 2024
0
0
At the Pacific Neuroscience Institute in Santa Monica, scientists are eager to explore whether a psychedelic chemical found in a toad could help people whose depression has not eased with typical treatments. Patients regularly ...
Jan 19, 2024
0
16
Most people infected with the SARS-CoV-2 virus recover after the acute illness. However, a significant proportion of infected individuals develop long-lasting symptoms with a wide range of manifestations. Long COVID's causes ...
Jan 18, 2024
0
18
Generative artificial intelligence could transform health care through things like drug development and quicker diagnoses, but the World Health Organization warned Thursday of the potential pitfalls in rushing to embrace ...
Jan 18, 2024
0
0
Researchers in the Department of Anesthesia and Perioperative Medicine at the Medical University of South Carolina (MUSC) have found that an FDA-approved drug may help to decrease pain after surgery. In the pilot study published ...
Jan 13, 2024
0
17
Indiana University neuroscientists have found the first evidence that rodents can call upon their episodic memory—the ability to recall seemingly unimportant streams of events from the past—and use incidentally encoded ...
Jan 12, 2024
0
62
The legalization of cannabis in Canada is driving the demand for scientifically backed insights to inform public health messaging.
Jan 11, 2024
0
22
Soy compounds called isoflavones are among the plant-derived compounds that may significantly reduce the risk of breast cancer recurrence or death, according to a new meta-analysis co-directed by investigators from the Johns ...
Jan 10, 2024
0
1
Cutaneous melanoma is considered the deadliest form of skin cancer because it's aggressive and tends to spread quickly through the body. While scientists have made significant progress in understanding the molecular mechanisms ...
Jan 9, 2024
0
0
Thirty years ago, Gail Sonenshein was studying cancer in immune cells when she read an article in the New York Times that would shape the rest of her career. The article described a new residency program in women's health, ...
Jan 9, 2024
0
0
